New Approaches to Optimize Asparaginase Therapy in the Management of Acute Lymphoblastic Leukemia

Download All
Get up to date on the latest strategies for integrating asparaginase-containing chemotherapy regimens into the management of ALL in adolesent/young adult and adult patients with this educational program featuring an on-demand webcast and downloadable slidesets from a live CCO symposium, along with a companion FAQ commentary where experts answer audience questions from the live program.
Daniel J. DeAngelo, MD, PhD
Program Director
Emily Curran, MD
Kjeld Schmiegelow, MD

Downloadable Slidesets

Download this slideset from a live CCO symposium for an expert overview of how to identify and optimally manage hypersensitivity reactions associated with asparaginase-based regimens in the treatment of ALL.

Kjeld Schmiegelow, MD Released: June 7, 2022

Download this slideset from a live CCO symposium for an expert overview on applying pediatric ALL regimens to the treatment of AYA and adult patients with ALL.

Daniel J. DeAngelo, MD, PhD
Program Director
Released: June 6, 2022

Download this slideset from a live CCO symposium for an expert overview of adverse events associated with asparaginase-based therapy in patients with ALL, including factors contributing to their development.

Emily Curran, MD Released: June 6, 2022

On-Demand Webcast

In this on-demand webcast from a live symposium, oncology experts Daniel J. DeAngelo, MD, Emily Curran, MD, and Kjeld Schmiegelow, MD, discuss the latest evidence to optimize the care of AYA and adult patients with acute lymphoblastic leukemia using asparaginase-based therapies.

Daniel J. DeAngelo, MD, PhD
Program Director
Emily Curran, MD Kjeld Schmiegelow, MD
Physicians: maximum of 1.5 AMA PRA Category 1 Credits Released: June 7, 2022 Expired: June 6, 2023
Provided by Clinical Care Options, LLC

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Supported by an educational grant from
Jazz Pharmaceuticals, Inc.

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Cookie Settings